NCT05362188View on ClinicalTrials.gov

Topical Nicotinamide in Treatment of DLE

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

September 1, 2022

Study Completion Date

September 30, 2022

Conditions
Discoid Lupus Erythematosus
Interventions
DRUG

Nicotinamide Topical

"Patients with discoid lupus erythematosus (face \& scalp) will be given topical nicotinamide in two concentrations (2\&4%) to apply twice daily for 12 consecutive weeks and then follow up.~Topical nicotinamide will be prepared in different forms (cream \& gel)."

Trial Locations (1)

11865

AL-Azhar University Hospital, Cairo

All Listed Sponsors
lead

Al-Azhar University

OTHER